PROBeX: Exit from Study SOP (1291)
PROBeX SOPTB/Coinfection Studies PROBeXDecisionResistanceBedaquilineGeneticMechanismsInteractionsPharmakineticSynthesisMedicationsRitonavirLopinavir Exit Death LostTerminationVoluntarilyAbsence XDRFollow-upManagement StudyTesting DrugExclusionWithdrawal ARTTreatment AfricaTuberculosisPatientDiagnosis HIVInternational 2020ClinicalCommunity HealthImmunologyVirologyGeneticsProspective Cohort StudyQuantitativeClinical
PROBeX exit from study SOP.